{"name":"Shanghai Eye Disease Prevention and Treatment Center","slug":"shanghai-eye-disease-prevention-and-treatment-center","ticker":"","exchange":"","domain":"","description":"The Shanghai Eye Disease Prevention and Treatment Center is a specialized institution focused on the prevention, treatment, and research of eye diseases. It is actively involved in clinical trials for low-concentration atropine formulations to address myopia progression.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Atropine Sulfate 0.01% Eye Drop","genericName":"Atropine Sulfate 0.01% Eye Drop","slug":"atropine-sulfate-0-01-eye-drop","indication":"Other","status":"marketed"},{"name":"Atropine Sulfate 0.04% Eye Drop","genericName":"Atropine Sulfate 0.04% Eye Drop","slug":"atropine-sulfate-0-04-eye-drop","indication":"Mydriasis and cycloplegia for diagnostic purposes","status":"marketed"}]}],"pipeline":[{"name":"Atropine Sulfate 0.01% Eye Drop","genericName":"Atropine Sulfate 0.01% Eye Drop","slug":"atropine-sulfate-0-01-eye-drop","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Atropine Sulfate 0.04% Eye Drop","genericName":"Atropine Sulfate 0.04% Eye Drop","slug":"atropine-sulfate-0-04-eye-drop","phase":"marketed","mechanism":"Atropine blocks muscarinic acetylcholine receptors in the eye to dilate the pupil and paralyze accommodation.","indications":["Mydriasis and cycloplegia for diagnostic purposes","Myopia control in children (off-label/emerging indication)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3AJBVV95cUxNdFUtblN4eXF6Mk5KcUdZdXNIZDA1WlFRWlhlNzMtcC1ON1NCc2huOFMyZjA2SjdJNWRrdERjY1oyclNIUUhvdW5OZld5Y2E3UFJ2Y3FHaGRIWDJWUUh3QmFPVjlNOXFWZC1rZTlMdENVTlRjQ2FROExYUGRINlBCazUtbC10OThtanVqejU2bHhybDdiNFJKeEgtcGRHSG5lTG4tMkhPMWpEYVVGYmlBQjFfdDJNUXVKRkRnMnJXVTBnZWdQLWhzdlVhclZEX3hTSzF2VTJBRHJFUkdHQW5yT1hBUnVJSnpieU1xLUVmMDhxdEQ5ak5yOEhzcFdnN0h5c0ZoSmstNEVTRElOWEY3YzZGdnlLUk9IbWZxQzVFM3oxdkhaVXUxdFEzUV9GYWh4TkxHQ0N5eTk2QjhIdk1PSGtqSkdYbFhwQV9OYjN3NTN3X2NYS3hlRGItU0s?oc=5","date":"2025-12-16","type":"deal","source":"BioSpace","summary":"GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Biosci","headline":"GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE91WllaNEtSNUlhSjZtOGRnWm50YjlZUHdVRTNEZDNkQ3ZWTmV0akZmWVNsemxVcVBIQ3J1ODFMSU1QQVRpNUJySjV5eEZ4b2FBdFpmSW5sUWU1UDB5QnBfUGJBR2NQRV9tNmZ0SlNMUjZMTlVhU2JwR3BpbFhRZw?oc=5","date":"2025-11-09","type":"pipeline","source":"China Daily","summary":"Haier Group promotes AI in healthcare at Shanghai expo - China Daily","headline":"Haier Group promotes AI in healthcare at Shanghai expo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQQUpvUWQ4d3d2dGI1cjNkSjg2X0xoNWNBTjRFQ2pGcG13MVh6QkRULWtZQWdjWXhKU3NiQ3lvOWNyYjlnQnBwRGJtWWhTUUVLeDZrTTh6VGZoaUJ5ejYyTUhhc0NaNTlVSHJXYlZOMWF1OUxscHB1OGxhb1JScnpfa2pndy1qbDI1ajdhUjRKT0NRMHNvVHlVTjAwVnVTU0l1cEVmT3gwNmRkRW5EYzVKMlV3?oc=5","date":"2025-07-30","type":"regulatory","source":"Yicai Global","summary":"Changchun High-Tech Gains After US FDA Approves Its Children's Hypertension Drug - Yicai Global","headline":"Changchun High-Tech Gains After US FDA Approves Its Children's Hypertension Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqYUJjUjFJc0dXMFZzRUV2MC1yQ0tVZjJhbGhEdFFseWpleFp5MG5wZExSbUhtekNQNVNrVmlodkRHU1MzY3VYQ2xvMXB0NHF1U0QyMXFORjZkand3SExB?oc=5","date":"2025-07-01","type":"pipeline","source":"Nature","summary":"Assessment of relative peripheral refraction in children with low myopia and pre-myopia using multispectral refraction topography - Nature","headline":"Assessment of relative peripheral refraction in children with low myopia and pre-myopia using multispectral refraction t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOal9XWURDaGNNRFhFZDY5YXBGeGlRTk1JY2VSS3RMOWctc2NHdGstT2NoLUI2QW5PQ2llaE16RVBZZzNfS01rbEsxZG1OeVlDaEtfRnJETjVlZjJSRHR6bUtacEVoRmE1U2UzdnRiajZkQWZZY2xkN0ZBSnFaQVZMWEEyQkU3UklwNG5FNGI1bngzZ2VkU0w4d3pWaEJESWRib0hPT0xGSzN4TmhVVTA5SUtPNkZremtsYmhqTEFtbGtIb0JjR1RZNDhNOWtrQ3ZJY1B2TldPemZMR1VXUDRhb0pGVTc?oc=5","date":"2025-04-02","type":"pipeline","source":"Yicai Global","summary":"Bayer Pharmaceuticals Prepares for a Landmark Year with Key Product Launches, Strategic Focus on China Amid Challenges - Yicai Global","headline":"Bayer Pharmaceuticals Prepares for a Landmark Year with Key Product Launches, Strategic Focus on China Amid Challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOZXBwTUVfMXZiVlh5NXdxaFVaT3hjRExIS0RjcC1vS0M3Vktoc240UGZ1S2pIbmdJLW5hZjd0YUF2dTZCTlFreEhFQUdzSVhZaGVYMWFBS2k2bTk2Qmw3TkpnckNkODJMQzBaMXNuMkN5VGVZMXQ3cFBxRHlTbXY1NkswQzd6Tk1WMk9ZREtpbVlvNzZoc0E?oc=5","date":"2024-02-09","type":"pipeline","source":"Frontiers","summary":"Changes and related factors of blood CCN1 levels in diabetic patients - Frontiers","headline":"Changes and related factors of blood CCN1 levels in diabetic patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOTV93Ym9zdGM2eVNZRVd4QWVwMHpGcE1POWU3OWVCajFUc0U5bmhIT2VnQkhtM2NPV2dRdl92cXBuQUlRS1MwMDlZdno4bExMS0N0VFptMEx6MzBJcnZMZ2hocDJZclFZbExUaG9uQ0NKUlpKN0ctRmRrbUxwdmlrX2JVZzVzZzdUNW1CNG5obDVITW9YVHVlaFNGSW85ZUJ3SzYxbHdBQnpWQdIBrAFBVV95cUxPQ2NXVFBlOVVjbWhQVHJRdzBBTW1vR3Z1eXlPYVlEVFFhMTYxbktaamFFeEhZaGlKc0dCWDF5ampjWGJJZVVhbUFHb1dHQk5sSS1XMWxWMXZYNmxQa1VUemxmd3hIamFiVUZFUzlGWVRHdm0zRXRFMFJ5MWJ0d193OHN6QjlRU3NvQktaM28wUGM2RVhaLTNrNlNqck1Yck1DMWl4ODhNY0ZIWkdq?oc=5","date":"2024-01-29","type":"pipeline","source":"VOA - Voice of America English News","summary":"Studies: Gene Treatment Lets Children Deaf at Birth Hear - VOA - Voice of America English News","headline":"Studies: Gene Treatment Lets Children Deaf at Birth Hear - VOA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBLZUE1eGRLc05fdlRhc2ZDVUplQmdUc0kwRmxuNklkWGZfOUFWdE5DMk5fSTNqcHdla3A5ejVmRzQ5UUtjX1h0UjBqM1pObkI4Q1pETlBtdlBhWTVKdTY4?oc=5","date":"2023-04-12","type":"trial","source":"Nature","summary":"The rate of orthokeratology lens use and associated factors in 33,280 children and adolescents with myopia: a cross-sectional study from Shanghai | Eye - Nature","headline":"The rate of orthokeratology lens use and associated factors in 33,280 children and adolescents with myopia: a cross-sect","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFB0WEtxWnVucWFjV29HSjgtVUpwZV9jS3dTbFVyWFg3eUU1UTV3VHM2VFlTaWI2R1dFMWZMR291b0Z2NGJVS25FdGRVVmdlVDlYUUFfd3hlZ09WZw?oc=5","date":"2022-05-21","type":"pipeline","source":"British Journal of Ophthalmology","summary":"Development of the retina and its relation with myopic shift varies from childhood to adolescence - British Journal of Ophthalmology","headline":"Development of the retina and its relation with myopic shift varies from childhood to adolescence","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}